HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of autophagy by stress-activated signals as a cellular self-defense mechanism against the cytotoxic effects of MBIC in human breast cancer cells in vitro.

Abstract
We recently reported that methyl 2-(-5-fluoro-2-hydroxyphenyl)-1H-benzo[d]imidazole-5-carboxylate (MBIC) is a microtubule targeting agent (MTA) with multiple mechanisms of action including apoptosis in two human breast cancer cell-lines MCF-7 and MDA-MB-231. In the present study, investigation of early molecular events following MBIC treatment demonstrated the induction of autophagy. This early (<24 h) response to MBIC was characterized by accumulation of autophagy markers; LC3-II, Beclin1, autophagic proteins (ATGs) and collection of autophagosomes but with different variations in the two cell-lines. MBIC-induced autophagy was associated with generation of reactive oxygen species (ROS). In parallel, an increased activation of SAPK/JNK pathway was detected, as an intersection of ROS production and induction of autophagy. The cytotoxic effect of MBIC was enhanced by inhibition of autophagy through blockage of SAPK/JNK signaling, suggesting that MBIC-induced autophagy, is a possible cellular self-defense mechanism against toxicity of this agent in both breast cancer cell-lines. The present findings suggest that inhibition of autophagy eliminates the cytoprotective activity of MDA-MB-231 and MCF-7 cells, and sensitizes both the aggressive and non-aggressive human breast cancer cell-lines to the cytotoxic effects of MBIC.
AuthorsMohadeseh Hasanpourghadi, Nazia Abdul Majid, Mohd Rais Mustafa
JournalBiochemical pharmacology (Biochem Pharmacol) Vol. 152 Pg. 174-186 (06 2018) ISSN: 1873-2968 [Electronic] England
PMID29608909 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 Elsevier Inc. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Benzimidazoles
  • Carboxylic Acids
  • Reactive Oxygen Species
  • methyl 2-(-5-fluoro-2-hydroxyphenyl)-1 H-benzo(d)imidazole-5-carboxylate
  • Extracellular Signal-Regulated MAP Kinases
Topics
  • Antineoplastic Agents (pharmacology)
  • Autophagy
  • Benzimidazoles (pharmacology)
  • Breast Neoplasms (drug therapy)
  • Carboxylic Acids (pharmacology)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Extracellular Signal-Regulated MAP Kinases (genetics, metabolism)
  • Female
  • Humans
  • Microscopy, Electron, Transmission
  • Reactive Oxygen Species

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: